All In Biotech

Free tool

FAERS Monitor: Metopirone

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 012911 or its brand name (Metopirone, Metyrapone). Reports on generic versions are filed under their own applications.

Reports

999

Serious

675

68% of reports

Hospitalization

323

Death reported

125

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use383
  • nausea81
  • drug ineffective66
  • fatigue53
  • vomiting53
  • adrenal insufficiency45
  • asthenia41
  • dizziness41
  • death38
  • maternal exposure during pregnancy35
  • pneumocystis jirovecii pneumonia35
  • diarrhoea33
  • anaemia28
  • hypokalaemia27
  • premature baby27

Reports by year received

View as table
YearReports
20046
20053
20069
200711
20083
200910
201013
201116
201226
201329
201411
201515
201617
201734
201882
201931
202057
202179
202283
202380
2024138
2025132
2026114

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,160 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
adrenal insufficiencySignal4578.458.93,349
pneumocystis jirovecii pneumoniaSignal3573.653.22,429
premature babySignal2718.913.0440
hypokalaemiaSignal2712.38.5270
off label useSignal3839.28.52,916
maternal exposure during pregnancySignal358.36.0217
anaemiaSignal283.12.138
vomitingSignal532.41.842
astheniaSignal412.31.729
nauseaSignal812.21.751
dizziness411.71.312
fatigue531.41.17
diarrhoea331.10.80
drug ineffective661.10.80
death380.90.70

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.